Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: A prospective study

Lancet

Volumn 357, Issue 9261, 2001, Pages 1008-1011

  Christenson, Brith ^a   Lundbergh, Per ^a   Hedlund, Jonas ^a   Örtqvist, Åke ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PNEUMOKOCKVACCIN; VACCIN MOT INFLUENSA;

AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION; SWEDEN; VACCINATION;

EID: 0035978034     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04237-9     Document Type: Article

References (19)

1. Pneumococcal and influenza vaccination levels among adults ≥65 years (United States 1997)
2. Influenza vaccination of the elderly: Perceptions and policies of general practitioners and outcome of the 1985-86 immunisation program in Trent, UK
3. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial
4. Influenza vaccine effectiveness in preventing hospitalisation for pneumonia in the elderly
5. Clinical effectiveness of influenza vaccination in Manitoba
6. Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization
7. The efficacy and cost effectiveness of vaccinations against influenza among elderly persons living in the community
8. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic
9. Benefits of influenza vaccination of low-, intermediate-, and high-risk senior citizens
10. Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions
11. Influenza vaccination: Are we doing better than we think?
12. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind, population-based trial
13. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease
14. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine
15. Pneumococcal polysaccharide vaccine efficacy
16. Preventing pneumococcal bacteremia in patients at risk: Results of a matched case-control study
17. Influenza vaccination coverage among the elderly in the Göteborg area
18. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
19. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older